Department of Colon & Rectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, 9500 Euclid Ave, A30, Cleveland, OH, 44195, USA.
Langenbecks Arch Surg. 2024 Jun 8;409(1):178. doi: 10.1007/s00423-024-03356-2.
Limited data exist regarding the surgical outcomes of acute colonic pseudo-obstruction (ACPO), commonly referred to as Ogilvie syndrome, in modern clinical practice. The prevailing belief is that surgery should be avoided due to previously reported high mortality rates. We aimed to describe the surgical results of ACPO treated within our institution.
Our prospectively maintained colorectal surgery registry was queried for patients diagnosed with ACPO, who underwent surgery between 2009 and 2022. Postoperative complications were graded according to Clavien-Dindo (CD) classification. The primary outcome was postoperative mortality.
A total of 32 patients who underwent surgery for ACPO were identified. Overall, nonoperative therapy was initially administered to 21 patients (65.6%). The surgeries performed included total abdominal colectomy (15, 43.1%), ascending colectomy with end ileostomy (8, 25%), transverse colostomy (5, 15.6%), ileostomy and transverse colostomy (3, 9.4%), and Hartmann's operation (1, 3.1%). Severe postoperative complications (CD grade 3 or 4) occurred in five patients (15.6%). No recurrence of ACPO was observed and no patient required reoperation. The average postoperative length of stay was 14.5 days, 30-day mortality was 6.3% (n = 2), and 90-day mortality was 15.6% (n = 5) due to complications of underlying comorbidities.
Surgical treatment was effective for patients with ACPO refractory to medical therapy or presenting with acute complications. Although postoperative complications were frequent, both the 30- and 90-day mortality rates were lower than previously documented in the literature. Further investigations are warranted to determine the optimal surgical strategy, which may involve total or segmental colectomy, or diversion alone without resection.
关于急性结肠假性梗阻(ACPO),通常称为奥吉尔维氏综合征的手术治疗结果,在现代临床实践中仅有有限的数据。普遍认为,由于先前报道的高死亡率,应避免手术。我们旨在描述在我们机构中治疗 ACPO 的手术结果。
我们对 2009 年至 2022 年间诊断为 ACPO 并接受手术的患者进行了前瞻性维护的结直肠手术登记处查询。根据 Clavien-Dindo(CD)分类对术后并发症进行分级。主要结果是术后死亡率。
共确定了 32 例接受 ACPO 手术的患者。总体而言,最初对 21 名患者(65.6%)进行了非手术治疗。进行的手术包括全腹部结肠切除术(15 例,43.1%)、升结肠切除术加末端回肠造口术(8 例,25%)、横结肠切除术(5 例,15.6%)、回肠造口术和横结肠造口术(3 例,9.4%)和 Hartmann 手术(1 例,3.1%)。五名患者(15.6%)发生严重术后并发症(CD 分级 3 或 4)。未观察到 ACPO 复发,也无需再次手术。平均术后住院时间为 14.5 天,30 天死亡率为 6.3%(n=2),90 天死亡率为 15.6%(n=5),这是由于潜在合并症的并发症所致。
对于对药物治疗无反应或出现急性并发症的 ACPO 患者,手术治疗是有效的。尽管术后并发症频繁,但 30 天和 90 天的死亡率均低于文献中先前记录的死亡率。需要进一步研究以确定最佳手术策略,该策略可能涉及全结肠或节段性结肠切除术,或单独不切除而进行转流术。